Lidocaine Hydrochloride Injection, USP
20 mg/mL
400 mg/20 mL
Multiple Dose Plastic Fliptop Vial
Unit of Sale NDC: 00409-4277-01
| Wholesalers | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardinal | 1496199 | ||||||||||||||||||
| Cencora | 10025371 | ||||||||||||||||||
| McKesson | 2717189 | ||||||||||||||||||
| Morris & Dickson | 505313 | ||||||||||||||||||
| Ordering information | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unit of Sale size | 1 Pack of 25 Vials | ||||||||||||||||||
| Case size | 4 x 25 | ||||||||||||||||||
| Cases per pallet | 147 | ||||||||||||||||||
| Allergy information | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-DEHP | |||||||||||||||||||
| Latex information | |||||||||||||||||||
| Availability specifics | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional information | View | ||||||||||||||||||
If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.
If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.
Cap color: Dark Blue
Unit of Sale NDC:
Unit of Use NDC:
Additional family SKUs (8)
Lidocaine Hydrochloride Injection, USP
50 mg/5 mL
Glass Ampul
Lidocaine Hydrochloride Injection, USP
200 mg/20 mL
Multiple Dose Plastic Fliptop Vial
Lidocaine Hydrochloride Injection, USP
300 mg/20 mL
Glass Ampul
07/2025
3Q 2025
Lidocaine Hydrochloride Injection, USP
20 mg/ 2 mL
Glass Ampul
Lidocaine Hydrochloride Injection, USP
300 mg/30 mL
Single Dose Glass Teartop Vial
Lidocaine Hydrochloride Injection, USP
40 mg/2 mL
Glass Ampul
Lidocaine Hydrochloride Injection, USP
200 mg/10 mL
Glass Ampul
Lidocaine Hydrochloride Injection, USP
1,000 mg/50 mL
Multiple Dose Plastic Fliptop Vial
07/2025
3Q 2025